-
MHY1485: mTOR Activator for Autophagy Workflows
2026-09-21
MHY1485 is a research-grade mTOR activator that helps dissect how mTOR signaling influences autophagy, cell survival, and tissue growth. Its value is greatest in paired assays that distinguish autophagosome accumulation from completed autophagic flux, with additional utility in ovarian follicle development research.
-
3-Bromopyruvate Overcomes Cetuximab Resistance
2026-09-21
The reference study shows that 3-bromopyruvate combined with cetuximab can suppress colorectal cancer models that are intrinsically or adaptively resistant to cetuximab. Its central mechanistic insight is that FOXO3a restoration coordinates AMPKα/pBeclin1-associated autophagy, ferroptosis, and PUMA-linked apoptosis, providing a rationale for combination treatment research.
-
N2703: From Nicotine Biosynthesis to Assay Design
2026-09-20
Explore how 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) can be positioned as a chemically defined probe for mechanism-focused assays. This article connects the complete nicotine biosynthesis pathway with practical identity controls, orthogonal readouts, and responsible interpretation of cellular signaling data.
-
Cell Cycle Assay Kit: From DNA Content to Mechanism
2026-09-19
The Cell Cycle Assay Kit converts PI-derived DNA content into an interpretable map of cell-cycle arrest and apoptosis. This guide applies K2263 to GANT61-treated ALK-positive lymphoma models while clarifying controls, limitations, and complementary assays.
-
Alternariol (AOH): Mechanisms and Workflows
2026-09-18
Alternariol, also called AOH, is an Alternaria-derived mycotoxin used to study cellular toxicity, hepatic stellate-cell activation, apoptosis, and cytochrome P450 biology. Recent evidence links AOH exposure to fibrotic phenotypes in LX-2 cells, while product specifications support controlled solvent selection and cold storage for reproducible assays.
-
Annexin V-PE Reagent for CD38 CAR-T Studies
2026-09-18
Connect CD38 CAR-binder design with a rapid phosphatidylserine readout using Annexin V-PE Reagent. The workflow supports parallel analysis of target-cell apoptosis, CAR-T fratricide, and assay quality by flow cytometry or fluorescence microscopy.
-
Tigecycline Workflows for MDR Bacterial Research
2026-09-17
Tigecycline is a glycylcycline antibiotic suited to standardized phenotypic testing across MRSA, GISA, and carbapenem-resistant Enterobacter cloacae research. This workflow-focused guide connects 30S ribosomal inhibition with plasmid-transmission studies, assay controls, and practical troubleshooting.
-
p-Cresyl Sulfate and Aortic Valve Calcification
2026-09-17
A 2026 study identifies p-cresyl sulfate as a direct enhancer of calcification in porcine aortic valvular interstitial cells and links this effect to HIF-1α activation, klotho loss, and NF-κB/RUNX2 signaling. The findings extend research on this protein-bound uremic toxin from vascular injury to calcific aortic valve disease and nominate klotho and SIRT1 as mechanistically relevant intervention points.
-
KCNE4-Dependent Modulation of Kv1.3 Pharmacology
2026-09-16
The reference study shows that KCNE4 changes the pharmacological behavior of Kv1.3 primarily by slowing intracellular Psora-4 inhibition rather than by substantially changing blocker affinity. This finding links auxiliary-subunit composition to assay kinetics and has practical implications for research on T cell Ca2+ signaling and immunomodulator targeting Kv1.3.
-
Ginsenoside Rg1 and the Gut–Brain Assay
2026-09-16
Ginsenoside Rg1 offers a mechanistically grounded way to study neuroimmune disruption after prolonged anesthesia. This guide translates Treg-dependent gut–immune–brain findings into practical assay, handling, and translational decision frameworks.
-
Sodium Oxamate: LDH-A Workflow for Metabolic Studies
2026-09-15
Sodium Oxamate provides a water-soluble, mechanism-oriented way to test whether LDH-A activity, lactate production, and glycolytic remodeling drive a phenotype. This workflow connects cancer metabolism research with a carefully bounded antiviral application while emphasizing controls that distinguish metabolic causality from nonspecific toxicity.
-
Fast-Dissociating Antibodies for Single-Molecule Imaging
2026-09-15
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay to identify specific monoclonal antibodies that dissociate rapidly, directly from hybridoma cultures. The resulting Fab probes enabled multiplexed imaging and revealed rapid espin turnover within apparently stable F-actin cores of inner-ear stereocilia.
-
Mithramycin A Workflows for Cancer Research
2026-09-14
Mithramycin A converts metal-dependent binding to G-C-rich DNA into a practical perturbation strategy for transcription, c-myc regulation, and leukemia research. This workflow also shows how findings from a doxorubicin heart-failure study can inform assay design without overstating an unvalidated cardiac application.
-
LY2603618: Chk1 Inhibitor Workflow Guide
2026-09-14
LY2603618 provides a controllable way to study Chk1-dependent DNA damage tolerance, G2/M progression, and chemotherapy response. This workflow-focused guide connects concentration selection, phospho-H2AX, cell-cycle profiling, and combination testing while separating established product information from exploratory assay recommendations.
-
Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-09-13
Oligo (dT) 25 Beads provide a magnetic capture route for isolating polyadenylated eukaryotic mRNA from total RNA, cells, or tissues. They are appropriate for animal and plant samples and downstream RT-PCR, cDNA synthesis, and sequencing workflows, but they should not be treated as a general method for recovering non-polyadenylated RNA.